Stonepine Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History

Stonepine Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $650,000 - $1.03 Million	-200,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $700,000 - $1.93 Million	200,000 New	200,000 $800,000
Q4 2018 Feb 13, 2019	SELL	$7.26 - $13.29 $1.05 Million - $1.93 Million	-145,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.8 - $14.35 $986,000 - $2.08 Million	145,000 New	145,000 $2 Million

107

35.3M

153K

83.9K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $311M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.